和元生物技术（上海）股份有限公司第四届董事会第二次会议决议公告

Group 1 - The company held its fourth board meeting on July 22, 2025, to discuss the stock incentive plan [2][3] - The board approved the first grant of restricted stock under the 2025 stock incentive plan, with a grant date of July 22, 2025, at a price of 3.09 yuan per share, granting 2,996,400 shares to 61 eligible participants [3][9] - The decision was made unanimously with all 9 directors present, and the meeting complied with relevant laws and regulations [2][6] Group 2 - The stock incentive plan was previously approved at the third extraordinary shareholders' meeting on July 16, 2025, and the board confirmed that all conditions for the first grant had been met [11][12] - The restricted stock represents approximately 0.46% of the company's total share capital of 649,036,700 shares [14] - The plan allows for the stock to vest over a maximum period of 36 months, with specific vesting conditions [20][25] Group 3 - The board's remuneration and assessment committee verified that the grant conditions were satisfied and that the participants met the eligibility criteria [16][24] - The company will account for the stock incentive plan in accordance with relevant accounting standards, estimating the impact on financial performance [25][26] - Legal opinions confirm that the grant complies with applicable regulations and that necessary approvals have been obtained [28]